Remedium Lifecare Rights Issue Gains Momentum: 26% Subscribed Within First Two Days

Mumbai (Maharashtra) [India], May 5: The Rights Issue of Remedium Lifecare Ltd marks a significant milestone in the company’s growth journey. Remedium Lifecare is a rapidly growing company specializing in the trading and distribution of raw materials as part of supply chain management for the pharmaceutical industry. The issue has been receiving tremendous response from [...]

PNN
PNN Syndicated | Wire Content | Press Release • 27 Sep, 2026Chief Editor
May 5, 2025 • 5:21 PM
B
Business
NEWS CARD
Logo
Remedium Lifecare Rights Issue Gains Momentum: 26% Subscribed Within First Two Days
“Remedium Lifecare Rights Issue Gains Momentum: 26% Subscribed Within First Two Days”
Favicon
Read more onen.marudharabharti.com
5 May 2025
https://en.marudharabharti.com/remedium-lifecare-rights-issue-gains-momentum-26-subscribed-within-first-two-days
Copied
Remedium Lifecare Rights Issue Gains Momentum: 26% Subscribed Within First Two Days
Remedium Lifecare Rights Issue Gains Momentum: 26% Subscribed Within First Two Days

Mumbai (Maharashtra) [India], May 5:The Rights Issue of Remedium Lifecare Ltd marks a significant milestone in the company’s growth journey. Remedium Lifecare is a rapidly growing company specializing in the trading and distribution of raw materials as part of supply chain management for the pharmaceutical industry. The issue has been receiving tremendous response from investors and shareholders, with a subscription of 26.03% by the end of Day 2.

The capital raised will be strategically utilized to accelerate global expansion initiatives, strengthen the company’s footprint in key international markets, and strengthening working capital, Investment in R&D capabilities thereby improving the overall financial health of the organization. By reinforcing its balance sheet and enhancing operational capabilities, Remedium Lifecare aims to unlock significant long-term value for its investors, positioning itself as a leading player in the global specialty chemicals and pharmaceutical sectors.

rss_feed Disclaimer
Story published through syndicated feed
favorite Follow us for the latest updates:
PNN

PNN Syndicated | Wire Content | Press Release • 27 Sep, 2026Chief Editor

homeHomeamp_storiesWeb Storieslocal_fire_departmentTrendingplay_circleVideosmark_email_unreadNewsletter